Dataset Information

New species in the Old World: Europe as a frontier in biodiversity exploration, a test bed for 21st century taxonomy.

ABSTRACT: The number of described species on the planet is about 1.9 million, with ca. 17,000 new species described annually, mostly from the tropics. However, taxonomy is usually described as a science in crisis, lacking manpower and funding, a politically acknowledged problem known as the Taxonomic Impediment. Using data from the Fauna Europaea database and the Zoological Record, we show that contrary to general belief, developed and heavily-studied parts of the world are important reservoirs of unknown species. In Europe, new species of multicellular terrestrial and freshwater animals are being discovered and named at an unprecedented rate: since the 1950s, more than 770 new species are on average described each year from Europe, which add to the 125,000 terrestrial and freshwater multicellular species already known in this region. There is no sign of having reached a plateau that would allow for the assessment of the magnitude of European biodiversity. More remarkably, over 60% of these new species are described by non-professional taxonomists. Amateurs are recognized as an essential part of the workforce in ecology and astronomy, but the magnitude of non-professional taxonomist contributions to alpha-taxonomy has not been fully realized until now. Our results stress the importance of developing a system that better supports and guides this formidable workforce, as we seek to overcome the Taxonomic Impediment and speed up the process of describing the planetary biodiversity before it is too late.

SUBMITTER: Fontaine B

PROVIDER: S-EPMC3359328 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

New species in the Old World: Europe as a frontier in biodiversity exploration, a test bed for 21st century taxonomy.

Fontaine Benoît B van Achterberg Kees K Alonso-Zarazaga Miguel Angel MA Araujo Rafael R Asche Manfred M Aspöck Horst H Aspöck Ulrike U Audisio Paolo P Aukema Berend B Bailly Nicolas N Balsamo Maria M Bank Ruud A RA Belfiore Carlo C Bogdanowicz Wieslaw W Boxshall Geoffrey G Burckhardt Daniel D Chylarecki Przemysław P Deharveng Louis L Dubois Alain A Enghoff Henrik H Fochetti Romolo R Fontaine Colin C Gargominy Olivier O Gomez Lopez Maria Soledad MS Goujet Daniel D Harvey Mark S MS Heller Klaus-Gerhard KG van Helsdingen Peter P Hoch Hannelore H De Jong Yde Y Karsholt Ole O Los Wouter W Magowski Wojciech W Massard Jos A JA McInnes Sandra J SJ Mendes Luis F LF Mey Eberhard E Michelsen Verner V Minelli Alessandro A Nieto Nafrıa Juan M JM van Nieukerken Erik J EJ Pape Thomas T De Prins Willy W Ramos Marian M Ricci Claudia C Roselaar Cees C Rota Emilia E Segers Hendrik H Timm Tarmo T van Tol Jan J Bouchet Philippe P

PloS one 20120523 5

The number of described species on the planet is about 1.9 million, with ca. 17,000 new species described annually, mostly from the tropics. However, taxonomy is usually described as a science in crisis, lacking manpower and funding, a politically acknowledged problem known as the Taxonomic Impediment. Using data from the Fauna Europaea database and the Zoological Record, we show that contrary to general belief, developed and heavily-studied parts of the world are important reservoirs of unknown ...[more]

PMID: 22649502

Similar Datasets

Project description:There is no good science in bad models. Cell culture is especially prone to artifacts. A number of novel cell culture technologies have become more broadly available in the 21st century, which allow overcoming limitations of traditional culture and are more physiologically relevant. These include the use of stem-cell derived human cells, cocultures of different cell types, scaffolds and extracellular matrices, perfusion platforms (such as microfluidics), 3D culture, organ-on-chip technologies, tissue architecture, and organ functionality. The physiological relevance of such models is further enhanced by the measurement of biomarkers (e.g., key events of pathways), organ specific functionality, and more comprehensive assessment cell responses by high-content methods. These approaches are still rarely combined to create microphysiological systems. The complexity of the combination of these technologies can generate results closer to the in vivo situation but increases the number of parameters to control, bringing some new challenges. In fact, we do not argue that all cell culture needs to be that sophisticated. The efforts taken are determined by the purpose of our experiments and tests. If only a very specific molecular target to cell response is of interest, a very simple model, which reflects this, might be much more suited to allow standardization and high-throughput. However, the less defined the end point of interest and cellular response are, the better we should approximate organ- or tissue-like culture conditions to make physiological responses more probable. Besides these technologic advances, important progress in the quality assurance and reporting on cell cultures as well as the validation of cellular test systems brings the utility of cell cultures to a new level. The advancement and broader implementation of Good Cell Culture Practice (GCCP) is key here. In toxicology, this is a major prerequisite for meaningful and reliable results, ultimately supporting risk assessment and product development decisions.

Dataset Information

New species in the Old World: Europe as a frontier in biodiversity exploration, a test bed for 21st century taxonomy.

Publications

New species in the Old World: Europe as a frontier in biodiversity exploration, a test bed for 21st century taxonomy.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure